Search Results - "Schnitzer, T.J."

A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee by Schnitzer, T.J, Marks, J.A

“…Summary To evaluate the efficacy and safety of anti-NGF antibody treatment in hip and knee osteoarthritis (OA), a systematic review and meta-analysis was…”
Get full text

Update on pharmacologic management of osteoarthritis by Schnitzer, T.J

Get full text

The Emotional Brain as a Predictor and Amplifier of Chronic Pain by Vachon-Presseau, E., Centeno, M.V., Ren, W., Berger, S.E., Tétreault, P., Ghantous, M., Baria, A., Farmer, M., Baliki, M.N., Schnitzer, T.J., Apkarian, A.V.

“…Human neuroimaging studies and complementary animal experiments now identify the gross elements of the brain involved in the chronification of pain. We briefly…”
Get full text

OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis by Losina, E, Ranstam, J, Collins, J.E, Schnitzer, T.J, Katz, J.N

“…Summary To highlight methodologic challenges pertinent to design, analysis, and reporting of results of randomized clinical trials in OA and offer practical…”
Get full text

Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain by Schnitzer, T.J, Lane, N.E, Birbara, C, Smith, M.D, Simpson, S.L, Brown, M.T

“…Summary Objective This study was designed to evaluate the long-term safety and effectiveness of repeated doses of the humanized anti-nerve growth factor…”
Get full text

Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study by Schnitzer, T.J, Kivitz, A, Frayssinet, H, Duquesroix, B

“…Summary Objective To evaluate the efficacy and safety of the cyclooxygenase-inhibiting nitric-oxide donator, naproxcinod, compared with naproxen and placebo in…”
Get full text

Fasinumab in the treatment of hip and knee osteoarthritic pain: efficacy and safety in a 36-week randomized, double-blind placebo-controlled clinical trial by Maloney, J, Kivitz, A, Schnitzer, T.J, Dakin, P, Di Martino, S, Gao, H, Stehman-Breen, C, Geba, G

Get full text

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab by Hunter, D.J., Schnitzer, T.J., Hall, J., Semel, D., Davignon, I., Cappelleri, J.C., Bushmakin, A.G., Abraham, L.

“…To assess onset of effect in three placebo- or nonsteroidal anti-inflammatory drug (NSAID)-controlled trials of tanezumab in patients with moderate-to-severe…”
Get full text

Cortical singularity of knee osteoarthritis patients and their response to duloxetine or placebo treatment by Tetreault, P, Baliki, M, Vachon-Presseau, E, Yeasted, R, Schnitzer, T.J, Apkarian, A

Get full text

OA pain shows anti-persistent time series by Schnitzer, T.J, Yeasted, R, Huang, L, Baliki, M, Apkarian, A

Get full text

I-20 IMPACT OF OSTEOARTHRITIS PAIN ON THE BRAIN by Schnitzer, T.J, Apkarian, A.V

Get full text

Subregional femorotibial cartilage morphology in women – comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis by Hellio Le Graverand, M.-P, Buck, R.J, Wyman, B.T, Vignon, E, Mazzuca, S.A, Brandt, K.D, Piperno, M, Charles, H.C, Hudelmaier, M, Hunter, D.J, Jackson, C, Kraus, V.B, Link, T.M, Majumdar, S, Prasad, P.V, Schnitzer, T.J, Vaz, A, Wirth, W, Eckstein, F

“…Summary Objective To identify subregional differences in femorotibial cartilage morphology between healthy controls and women with different grades of…”
Get full text

Brain functional properties predict placebo analgesia in knee osteoarthritis by Mansour, A, Baliki, M, Schnitzer, T.J, Apkarian, A.V

Get full text

Performance of a non-fluoroscopically assisted substitute for the Lyon schuss knee radiograph: quality and reproducibility of positioning and sensitivity to joint space narrowing in osteoarthritic knees by Mazzuca, S.A., Ph.D, Hellio Le Graverand, M.-P., M.D, Vignon, E., M.D, Hunter, D.J., M.B.B.S., Ph.D, Jackson, C.G., M.D, Kraus, V.B., M.D, Link, T.M., M.D, Schnitzer, T.J., M.D, Vaz, A., M.D., Ph.D, Charles, H.C., Ph.D

“…Summary Objective This study evaluated the longitudinal performance of a modified Lyon schuss (LS) knee examination in the detection of radiographic joint…”
Get full text

330 EFFECTS OF NAPROXCINOD AND NAPROXEN ON CHANGE IN JOINT SPACE WIDTH IN THE TIBIO-FEMORAL JOINT: RESULTS OF A 52-WEEK, RANDOMIZED CONTROLLED TRIAL by Hochberg, M.C, Schnitzer, T.J, Marrero, C.E, Berembaum, F, Duquesroix, B, Frayssinet, H

Get full text

A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoarthritis by Schnitzer, T.J., M.D., Ph.D, Tesser, J.R.P., M.D, Cooper, K.M., M.S, Altman, R.D., M.D

“…Summary Objective To compare the safety and efficacy of acetaminophen extended-release (APAP ER) with rofecoxib for the management of pain associated with knee…”
Get full text

322 SAFETY OF TANEZUMAB IN TREATING MODERATE TO SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE: AN OPEN-LABEL EXTENSION STUDY by Lane, N.E, Schnitzer, T.J, Birbara, C.A, Smith, M.D, Simpson, S, Brown, M.T

Get full text

264 BASELINE PREDICTORS OF RESPONSE USING A POOLED ANALYSIS OF TWO RANDOMIZED CONTROLLED STUDIES IN CHRONIC LOW BACK PAIN (LBP) PATIENTS by Gammaitoni, A, Katz, N.P, Schnitzer, T.J, Mehta, A, Wang, H, Peloso, P

Get full text

263 LONGITUDINAL NUMBERS-NEEDED-TO-TREAT (NNT) ANALYSES OF ANALGESIC TREATMENTS FOR CHRONIC LOW BACK PAIN TO ACHIEVE VARYING RESPONSE LEVELS AND STABILITY by Schnitzer, T.J., Moore, R.A., Katz, N.P., Gammaitoni, A., Mehta, A., Wang, H., Peloso, P.

Get full text

Physical function status in hip and knee osteoarthritis: pain, psychological features and functional capacity play a major role by Espinosa-Salas, S., Bagherzadeh, L., Schnitzer, T.J., Barroso, J.

Get full text